Biosimilars, Pharmacy Management and Webinar

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Pharmacy Times

JUNE 20, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Vaccines

Vaccines Pharmacy Technician Immunization Immunity

Correct Patient Misconceptions Around Biosimilars

Pharmacy Times

JUNE 27, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Understanding Biologics and Biosimilars Amid an Evolving Treatment Landscape

Pharmacy Times

JUNE 12, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Real-World Data Shows Similar Clinical Outcomes in Patients Receiving Biosimilars Following Switch From Reference Product

Pharmacy Times

JULY 4, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

FDA Approves Ustekinumab-Stba, Biosimilar to Stelara, for Pediatric Patients With PsO or PsA

Pharmacy Times

JUNE 16, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Study Shows High-Dose Vitamin D Boosts Treatment Response in Breast Cancer

Pharmacy Times

JUNE 13, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Chemotherapy

Chemotherapy Pharmacy Technician Immunization Immunity

Breaking New Ground in Migraine Prevention: Eptinezumab-jjmr

Pharmacy Times

JULY 2, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Correct Patient Misconceptions Around Biosimilars

Trending Sources

Understanding Biologics and Biosimilars Amid an Evolving Treatment Landscape

Real-World Data Shows Similar Clinical Outcomes in Patients Receiving Biosimilars Following Switch From Reference Product

FDA Approves Ustekinumab-Stba, Biosimilar to Stelara, for Pediatric Patients With PsO or PsA

Study Shows High-Dose Vitamin D Boosts Treatment Response in Breast Cancer

Breaking New Ground in Migraine Prevention: Eptinezumab-jjmr

OTC Assessments With Recommendations and Counseling Should Be a Billable Encounter

Pharmacists Reimagine Myeloma Care With Insights from ASCO

Lorundrostat Shows Clinically Meaningful Outcomes in Patients With CKD and Hypertension

Walgreens Launches Program to Enable Technicians to Pursue Pharmacy School

Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy

FDA Approves Twice-Yearly Lenacapavir for HIV Preexposure Prophylaxis

FDA Removes REMS for Currently Approved BCMA-, CD19-Directed CAR T Cell Immunotherapies

FDA Approves Immunoglobulin Formulation With Low IgA Content for Primary Immunodeficiency

Spring 2025 Quiz: Test Your Pharmacy Knowledge!

Study Confirms Interchangeability of Hulio, Biosimilar of Humira, in Severe Chronic Plaque Psoriasis

OTC Case Studies: Summer Skin Care

Nitisinone Becomes First and Only FDA-Approved Treatment for HGA in Adults With AKU

Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating Factor

Ropeginterferon Alfa 2b Is Well-Tolerated, Efficacious in Treatment of Prefibrotic Myelofibrosis

Research Suggests Vitamin D Deficiency Is a Risk Factor for Autism

ADA 2025: Insights into Diabetes, Obesity, and Pharmacist's Role in Advancing Care

Nemolizumab Shows Rapid, Sustained Efficacy in Atopic Dermatitis

ADA 2025: Advances in Type 2 Diabetes Management With Tirzepatide

ADA 2025: CagriSema Demonstrates Significant Weight Loss in REDEFINE Clinical Trials

Inside the Synergy Between HOPA and OPC’s Evolving Educational Impact

Evaluation of a Pharmacy-Delivered Oncofertility Intervention

Steroid Use During ICI Treatment Lessens Effectiveness in Patients With NSCLC

The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

FDA Approves First, Only Single-Pill Triple Combination for Treatment of Hypertension

Taletrectinib Gains FDA Approval for Locally Advanced or Metastatic ROS1+ NSCLC

ADA 2025: Ready-to-Use Glucagon Empowers Diabetes Patient Safety

You Shall Not Pass: Pharmacist Review of Drug-Herb Interactions in Cancer Treatment

Real-World Data on Expanding Step-Up Dosing Administration of Bispecific T-Cell Engagers in the Outpatient Setting

FDA Approves Tablet Formulation of Zanubrutinib for All Indications

Atrium Health: Pioneering Outpatient Transplant Models Driven by Pharmacist-Led Care

Study Reveals Gaps in GINA Guideline Adherence for Asthma Treatment

New Drugs, New Decisions: How Pharmacists Are Guiding the Future of Hematologic Care

Pharmacies Need Strategies to Improve Health Care Access

Expanding Access: Digital Therapeutics and the Evolving Role of Pharmacists

Immunotherapy Takes the Lead in Advanced Cutaneous Malignancies

Reinventing Transplant Care: From Inpatient Tradition to Outpatient Innovation

Stay Connected